Participating Faculty for Moderate to Severe Psoriasis: Considerations for Patient Management Amid a Changing Treatment Spectrum
Treatment Strategies, Management of Comorbidities, and the Role of IL-23 Inhibitors in Moderate to Severe Psoriasis